Singer Roberta Flack can no longer sing after ALS diagnosis
Reuters
Published Nov 14, 2022 04:34PM ET
Updated Nov 14, 2022 07:16PM ET
LOS ANGELES (Reuters) - Grammy-winning musician Roberta Flack, whose hits include "Killing Me Softly with His Song," has been diagnosed with ALS, also known as Lou Gehrig's disease, and can no longer sing, her representatives said on Monday.
Amyotrophic lateral sclerosis, a progressive disease, "has made it impossible to sing and not easy to speak," a statement from her publicists said. "But it will take a lot more than ALS to silence this icon."
A documentary about Flack's life is set to debut at a film festival in New York next week. It will air on PBS television in the United States in January. Flack, 85, also is releasing a children's book in January.
ALS breaks down nerve cells in the brain and spinal cord that make muscles work, leading to progressive paralysis and death.
Flack had several No. 1 hits in the 1970s and produced 20 studio albums. She won four Grammys and was honored with a lifetime achievement award in 2020.
The singer also was the first artist to win two consecutive record of the year trophies in 1973 for "First Time I Ever Saw Your Face" and in 1974 for "Killing Me Softly with His Song."
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.